HSIC

Based on Henry Schein, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

What does Henry Schein do?

Henry Schein distributes healthcare products and services to dental offices, physician practices, and institutional clinics worldwide. It also provides practice management software, financial services, and continuing education through its Technology and Value-Added Services segment.

Does HSIC pay dividends?

Henry Schein does not currently pay a dividend. The company retains capital for operational needs, technology investment, and potential acquisitions rather than returning cash to shareholders through regular distributions.

When does HSIC report earnings?

Henry Schein reports financial results on a quarterly basis, in line with standard US-listed company practice. For exact dates and upcoming announcements, check the investor relations section of Henry Schein's official website.

Is HSIC a good stock to buy?

UQS Score rates HSIC as Below Average. While Valuation is rated Attractive, the Moat, Growth, and Risk pillars are all rated Weak. Whether that combination suits your portfolio depends on your risk tolerance and investment horizon. View the full pillar breakdown on UQS Score.

Is HSIC overvalued?

The UQS Valuation pillar for HSIC is rated Attractive, suggesting the stock is not considered expensive relative to its fundamentals at current levels. However, valuation alone does not determine investment merit — the weak growth and risk profile should be considered alongside it.

How does HSIC compare to its competitors?

Henry Schein occupies a specialized niche in dental and medical distribution alongside practice technology. Compared to larger distributors like Cardinal Health, HSIC is smaller in scale. Its UQS profile can be compared directly to peers using the competitor section on its UQS Score page.

What is HSIC's market cap bracket?

Henry Schein is classified as a mid-cap company. This places it in a range that typically offers more liquidity than small-caps while remaining more nimble than mega-cap healthcare conglomerates.

Who founded Henry Schein?

Henry Schein was originally founded as a pharmacy by Henry Schein himself in 1932. The company evolved over decades into a major healthcare distributor and was incorporated in its current form in 1995. Detailed founding history is widely available through public sources.

Is HSIC a long-term quality investment?

As a long-term quality indicator, HSIC's UQS profile raises caution — Moat and Growth are both rated Weak, which can limit compounding potential over time. The Attractive Valuation may offer some cushion, but long-term investors typically look for stronger moat and growth characteristics.

What is the main competitive advantage of Henry Schein?

Henry Schein's scale in dental distribution and its integrated software offerings create some switching costs among established customers. However, the UQS Moat pillar is rated Weak, indicating these advantages may not be durable enough to consistently fend off competitive pressure.

What sector does HSIC belong to?

Henry Schein operates in the Healthcare sector, specifically within healthcare distribution and practice technology services. It serves dental and medical professionals rather than end consumers, distinguishing it from retail-facing healthcare companies.

Is HSIC a growth stock or value stock?

Based on UQS pillar ratings, HSIC leans toward value territory — Valuation is rated Attractive while Growth is rated Weak. This profile is more consistent with a value-oriented holding than a high-growth opportunity, though neither label fully captures the risk profile.

Henry Schein, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.

Henry Schein, Inc. faces growth headwinds with declining or stagnant revenue trends.

Henry Schein, Inc. presents elevated risk with concerns around leverage or financial stability.

Henry Schein, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Henry Schein, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for HSIC.

The UQS (Unified Quality Score) for Henry Schein, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Henry Schein, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Henry Schein, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.